Bide Pharmatech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	153.31	117.43	109.57	145.97	97.57	59
Depreciation & Amortization	28.43	28.43	26.93	17.61	10.67	2.48
Other Amortization	15.25	15.25	14.16	8.62	7.47	5.61
Loss (Gain) From Sale of Assets	-0.86	-0.86	-0.44	-	-7.92	-0.09
Asset Writedown & Restructuring Costs	0.03	0.03	0	0	0.04	0.55
Loss (Gain) From Sale of Investments	-5.98	-5.98	8.87	0.4	-0.41	-0.5
Provision & Write-off of Bad Debts	1.75	1.75	4.33	3.52	3.06	2.24
Other Operating Activities	-86.46	41.23	20.11	-5.92	11.97	14.69
Change in Accounts Receivable	10.05	10.05	-45.02	-74.5	-58.02	-16.88
Change in Inventory	-96.65	-96.65	-196.27	-52.81	-267.2	-97.03
Change in Accounts Payable	43.2	43.2	-1.58	-14.89	134.92	25.74
Change in Other Net Operating Assets	1.69	1.69	12.32	-	1.99	8.97
Operating Cash Flow	66.5	158.31	-57.39	29.87	-64.88	3.65
Operating Cash Flow Growth	-59.95%	-	-	-	-	21.97%
Capital Expenditures	-27.04	-88.35	-61.08	-38.41	-29.2	-37.73
Sale of Property, Plant & Equipment	12.63	2.2	0.93	-	15.15	0.31
Investment in Securities	83.79	-77.92	-	0.59	43.41	-42.5
Other Investing Activities	3.47	5.59	4.06	-4.79	-	-
Investing Cash Flow	72.84	-158.48	-28.87	-42.61	29.36	-79.92
Short-Term Debt Issued	-	97.35	0.23	-	20.73	33.57
Long-Term Debt Issued	-	5.6	4.98	9.61	-	-
Total Debt Issued	267.73	102.94	5.21	9.61	20.73	33.57
Short-Term Debt Repaid	-	-68.01	-9.53	-	-37.69	-41.65
Long-Term Debt Repaid	-	-21.88	-21.83	-13.89	-8.53	-
Total Debt Repaid	-154.53	-89.89	-31.36	-13.89	-46.22	-41.65
Net Debt Issued (Repaid)	113.2	13.06	-26.14	-4.28	-25.49	-8.09
Issuance of Common Stock	-	-	-	1,335	163.9	160.25
Repurchase of Common Stock	-100.02	-100.02	-	-	-	-
Common Dividends Paid	-79.18	-79.88	-100.03	-0.08	-0.19	-24.91
Other Financing Activities	4.85	-	-12.13	-20.52	-0.77	-
Financing Cash Flow	-61.15	-166.84	-138.31	1,310	137.44	127.25
Foreign Exchange Rate Adjustments	-3.37	-1.44	-5.83	4.73	-0.3	-3.56
Net Cash Flow	74.82	-168.45	-230.39	1,302	101.62	47.42
Free Cash Flow	39.45	69.97	-118.47	-8.54	-94.09	-34.08
Free Cash Flow Margin	3.11%	6.35%	-10.85%	-1.02%	-15.52%	-8.71%
Free Cash Flow Per Share	0.45	0.79	-1.31	-0.12	-1.41	-0.55
Cash Income Tax Paid	1.61	19.77	2.5	25.48	12.74	14.34
Levered Free Cash Flow	-41.36	26.94	-188.91	-43.78	-120.54	-82.71
Unlevered Free Cash Flow	-39.04	29.01	-187.33	-42.42	-119.96	-81.54
Change in Working Capital	-38.96	-38.96	-240.92	-140.34	-187.34	-80.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.